Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2025-12-25 @ 12:04 AM
NCT ID:
NCT02929758
Eligibility Criteria:
Inclusion Criteria Parkinson's disease Subjects:
* Subjects with a clinical diagnosis of idiopathic Parkinson's disease based on the presence of bradykinesia and one or both of the following: rest tremor and/or rigidity
* On stable medications for at least 4 weeks prior to entering the study and expected to not need any medication changes for the duration of the study
* Age ≥50 at the time of entry into the study
* Age of onset of Parkinson's disease 45 - 85 years old
* Asymmetric onset of PD
* Progressive motor symptoms of PD
* Hoehn and Yahr stages 1-4
* Ability to walk up and down a single stair step
* Access to a computer with internet
Exclusion Criteria Parkinson's disease Subjects:
* Atypical features indicative of a Parkinson's Plus disorder (Progressive Supranuclear Palsy, Multiple Systems Atrophy, Corticobasal Degeneration) including cerebellar signs, supranuclear gaze palsy, apraxia, prominent autonomic failure, or other cortical signs.
* Neuroleptic treatment at time of onset of Parkinsonism
* Active treatment with a neuroleptic at time of study entry
* History of multiple strokes with stepwise progression of Parkinsonism
* History of multiple head injuries
* Inability to walk without assistance, including a cane, wheelchair, or walker
* Cognitive dysfunction that would prevent subject's ability to perform virtual reality simulation, speed of processing training, or complete questionnaire
* Blindness
* Any medical condition that, based on discretion of the PI, would prevent the subject's ability to participate in the study
Inclusion Criteria Control Subjects:
* Age ≥50 at the time of entry into the study
* On stable medications for at least 4 weeks prior to entering the study and expected to not need any medication changes for the duration of the study
* Ability to walk up and down a single stair step
* Access to a computer with internet
Exclusion criteria Control Subjects:
* Parkinson's disease or other neurodegenerative disorder
* Inability to walk without assistance, including a cane, wheelchair, or walker
* Cognitive dysfunction that would prevent subject's ability to perform virtual reality simulation, speed of processing training, or complete questionnaires
* Blindness
* Any medical condition that, based on the discretion of the PI, would prevent the subject's ability to participate in the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT02929758
Study Brief:
Protocol Section:
NCT02929758